Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Primary Care

Journal Scan / Research · January 21, 2015

Photodynamic Therapy vs Topical Imiquimod vs Topical Fluorouracil for Superficial Basal Cell Carcinoma

The British Journal of Dermatology

 

Additional Info

Disclosure statements are available on the authors' profiles:

The British Journal of Dermatology
Photodynamic Therapy Versus Topical Imiquimod Versus Topical Fluorouracil for Treatment of Superficial Basal-Cell Carcinoma: A Single Blind, Non-Inferiority, Randomised Controlled Trial: A Critical Appraisal
Br J Dermatol 2015 Jan 01;172(1)8-10, LL Lecluse, PI Spuls

Further Reading